From NCCTG, Mayo: two characteristics that identify poor-prognosis B2 colon cancer patients who might benefit from adjuvant chemotherapy.
D003110:Colonic Neoplasms / Q000188:drug therapy*; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis